Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
8.068 USD  +0.028 (+0.34%)
Streaming Delayed Price  /  Updated: 12:55 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Keryx Biopharmaceuticals, Inc.
 
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
37 38 Next >
Keryx Biopharmaceuticals (NASDAQ:KERX) Investor Alert: Investigation over Possible Violations of Securities Laws
November 06, 2012
San Diego, CA -- (SBWIRE) -- 11/06/2012 -- An investigation for investors in Keryx Biopharmaceuticals (NASDAQ:KERX) shares over potential securities laws violations by Keryx Biopharmaceuticals was... Read More
from SBWire - Latest Press Releases
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
November 02, 2012
from PR Newswire
Keryx Biopharmaceuticals Initiates Phase 2 Study of Zerenex™ (ferric citrate) for the Treatment of Patients with Non-Dialysis Dependent Chronic Kidney Disease
November 01, 2012
from PR Newswire
Hot Stock: Keryx Biopharmaceuticals, Shares Drop 7.2% (KERX)
October 23, 2012
from Comtex SmarTrend® News Briefs
A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.
October 19, 2012
from Marketwired News Releases
Leading Percent Gainers (JCP, WLT, KERX, GFA)
October 12, 2012
Los Angelas, CA -- (SBWIRE) -- 10/12/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
Free Reports on AuRico Gold, Amarin, Keryx, and Yum! Brands Provided by the Bedford Report
October 11, 2012
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Capital News Circuit Read More
from Marketwired News Releases
Disappointing Earnings Weigh Down Markets
October 10, 2012
Disappointing corporate earnings weighed the markets down during the midday with the Dow plunging 116 points to 13,357. Nasdaq lost 9 points to 3055. Read More
category Market News
from MarketMinute.com Market Updates
Hot Stock: Keryx Biopharmaceuticals, Shares Gain 7.3% (KERX)
October 10, 2012
from Comtex SmarTrend® News Briefs
VFC's Stock House: AEterna Zentaris (AEZS) Primed For A Rebound
October 10, 2012
from EmailWire.Com Press Releases
Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures
October 04, 2012
Five Star Equities Provides Stock Research on AspenBio Pharma and Keryx Biopharmaceuticals Read More
from Marketwired News Releases
Profit Stocks to Buy Now ( SNSS, KERX, NSPH, THR )
September 24, 2012
Los Angelas, CA -- (SBWIRE) -- 09/24/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... Read More
from SBWire - Latest Press Releases
Unusual 11 Mid-Day Movers 09/21: (HALO) (KERX) (SNSS) Higher; (PEIX) (BTH) (KBH) Lower
September 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7743586 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharma (KERX) Moves Higher on Volume (AEZS)
September 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7743486 for the full story. Read More
from StreetInsider.com News Articles
Top Pharma stocks: Halozyme Therapeutics, Keryx Biopharmaceuticals, Sunesis Pharmaceuticals, Merck & Co, Arena Pharmaceuticals
September 20, 2012
from ACCESSWIRE
VFC's Stock House: AEterna Zentaris A Potential Rebound And Growth Play Based On Pipeline Progress And Pending Catalysts
September 18, 2012
from EmailWire.Com Press Releases
Stock to Watch: Keryx Biopharmaceuticals Up 6.8% (KERX)
September 12, 2012
from Comtex SmarTrend® News Briefs
Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Reviewal Process
September 11, 2012
The Paragon Report Provides Stock Research on Dendreon and Keryx Biopharmaceuticals Read More
from Marketwired News Releases
3 Biotechnology Stocks to Sell Now
September 05, 2012
 Read More
category NASDAQ:ENZN , Stocks to Sell , NASDAQ:SVA , and 1 more.
from InvestorPlace - Latest Headlines
Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity
September 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7703571 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
September 05, 2012
from PR Newswire
Keryx Biopharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
August 31, 2012
Presentation Scheduled for Thursday, September 6th at 1:30pm ET Read More
from PR Newswire
Favorable Legislation Introduced in 2012 Helps Accelerate Biotech Industry Growth in 2012
August 20, 2012
Five Star Equities Provides Stock Research on Keryx Biopharmaceuticals and Galena Biopharma Read More
from Marketwired News Releases
6 Biotechnology Stocks to Sell Now
August 19, 2012
 Read More
category Stocks to Sell , NASDAQ:SVA , NASDAQ:MNTA , and 4 more.
from InvestorPlace - Latest Headlines
Keryx Biopharma (KERX) Posts Narrower than Expected Q2 Loss of 2c/Share
August 07, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7639113 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
August 07, 2012
Keryx to Host Investor Conference Call on Wednesday, August 8, 2012 at 8:30am EDT Read More
from PR Newswire
Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
August 06, 2012
Investor Conference Call to be held Wednesday, August 8, 2012 at 8:30am EDT Read More
from PR Newswire
4 Biotechnology Stocks to Sell Now
August 05, 2012
 Read More
category Stocks to Sell , NASDAQ:SVA , NASDAQ:SSRX , and 2 more.
from InvestorPlace - Latest Headlines
StemCells and Keryx Biopharmaceuticals Showing Strong Gains as Biotechnology Industry Soars in 2012
July 24, 2012
The Paragon Report Provides Stock Research on StemCells and Keryx Biopharmaceuticals Read More
from Marketwired News Releases
Four Small Biotechs You Should Know: (NASDAQ: KERX), (NASDAQ: GERN), (NASDAQ: CTIC), (OTCBB: ONCS)
July 10, 2012
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO NewsWire Read More
from Marketwired News Releases
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
37 38 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here